SCHEMBL528179

SCHEMBL528179

COC(=O)C1CN(C)CCC1c1ccc(C)c(F)c1

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 5/20 0.67
SLC6A4 P31645 5/20 0.67
SLC6A3 Q01959 5/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14920291 0.90 SLC6A2 (0.70) SLC6A2SLC6A4SLC6A3
SCHEMBL14920294 0.90 SLC6A2 (0.70) SLC6A2SLC6A4SLC6A3
SCHEMBL527575 0.86 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3
SCHEMBL952054 0.84 SLC6A2 (0.76) SLC6A2SLC6A4SLC6A3
SCHEMBL4792208 0.84 SLC6A2 (0.76) SLC6A2SLC6A4SLC6A3
SCHEMBL4661498 0.84 SLC6A2 (0.76) SLC6A2SLC6A4SLC6A3
SCHEMBL4507925 0.84 SLC6A2 (0.76) SLC6A2SLC6A4SLC6A3
SCHEMBL5110398 0.84 SLC6A2 (0.76) SLC6A2SLC6A4SLC6A3
SCHEMBL5905510 0.84 SLC6A2 (0.76) SLC6A2SLC6A4SLC6A3
Iodide SCHEMBL7746641 0.83 SLC6A2 (0.74) SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10087166-B2 Cyclic amine azaheterocyclic carboxamides MERCK PATENT GMBH (DE) 2018-10-02 US disclosed
US-20170129877-A1 Cyclic Amine Azaheterocyclic Carboxamides MERCK PATENT GMBH (DE) 2017-05-11 US disclosed
US-9586938-B2 Cyclic amine azaheterocyclic carboxamides MERCK PATENT GMBH (DE) 2017-03-07 US disclosed
US-20130217709-A1 Cyclic Amine Azaheterocyclic Carboxamides MERCK PATENT GMBH (DE) 2013-08-22 US disclosed
EP-2598497-A1 CYCLIC AMINE AZAHETEROCYCLIC CARBOXAMIDES Merck Patent GmbH (DE) 2013-06-05 EP disclosed
WO-2012016001-A1 CYCLIC AMINE AZAHETEROCYCLIC CARBOXAMIDES MERCK PATENT GMBH (DE) 2012-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217709-A1 Cyclic Amine Azaheterocyclic Carboxamides MKI67, AZI2, PCNA SLC6A2 3922/4885SLC6A4 4662/4885SLC6A3 4371/4885
US-20170129877-A1 Cyclic Amine Azaheterocyclic Carboxamides MKI67, AZI2, PCNA SLC6A2 3922/4885SLC6A4 4662/4885SLC6A3 4371/4885
US-10087166-B2 Cyclic amine azaheterocyclic carboxamides MKI67, AZI2, PCNA SLC6A2 3922/4885SLC6A4 4662/4885SLC6A3 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.